Facetten
Zugriff
Einrichtung
Medientyp
- Text 9
Karte
Erscheinungsjahr
Autor/in
- Hartkopf, Andreas D
- Schneeweiss, Andreas
- Belleville, Erik 6
- Janni, Wolfgang 6
- Ettl, Johannes 5
- alle zeigen
Sprache
- Englisch 9
9 Einträge gefunden
-
Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
- Schneeweiss, Andreas
- Ettl, Johannes
- Lüftner, Diana
- Beckmann, Matthias W
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
-
Update Breast Cancer 2020 Part 5 - Moving Therapies From Advanced to Early Breast Cancer Patients
- Lux, Michael P
- Schneeweiss, Andreas
- Hartkopf, Andreas D
- Müller, Volkmar
- Janni, Wolfgang
- Belleville, Erik
- Stickeler, Elmar
-
-
Update Breast Cancer 2020 Part 3 - Early Breast Cancer
- Huober, Jens
- Schneeweiss, Andreas
- Hartkopf, Andreas D
- Müller, Volkmar
- Lux, Michael P
- Janni, Wolfgang
- Ettl, Johannes
-
HER2-targeted therapy influences CTC status in metastatic breast cancer
- Deutsch, Thomas M
- Riethdorf, Sabine
- Fremd, Carlo
- Feisst, Manuel
- Nees, Juliane
- Fischer, Chiara
- Hartkopf, Andreas D
-
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany
- Schneeweiss, Andreas
- Ettl, Johannes
- Lüftner, Diana
- Beckmann, Matthias W
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
-
-
-
Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers
- Taran, Florin-Andrei
- Schneeweiss, Andreas
- Lux, Michael P
- Janni, Wolfgang
- Hartkopf, Andreas D
- Nabieva, Naiba
- Overkamp, Friedrich